Skip to main content

Table 1 The characteristics of the total participants and patients with or without CKD

From: The association of metabolic syndrome components and chronic kidney disease in patients with hypertension

 Total
(N = 2484)
CKD (−)
(N = 1937)
CKD (+)
(N = 547)
p
Age (year)65.12 ± 12.7164.28 ± 12.5368.09 ± 12.94< 0.01
Male (%)55.9%57.9%49.0%< 0.01
Systolic BP (mmHg)142.30 ± 17.68142.15 ± 17.64142.81 ± 17.810.44
Diastolic BP (mmHg)83.01 ± 11.9382.92 ± 12.0983.35 ± 11.340.45
Hypertension grades (%)   0.16
 Controlled41.6%42.8%37.5% 
 136.9%36.3%39.0% 
 214.9%14.4%16.5% 
 36.7%6.6%7.0% 
Antihypertensive therapy (%)90.7%90.7%90.7%0.99
TG (mmol/L)1.62(1.14, 2.3)1.60(1.11–2.26)1.77(1.28–2.42)< 0.01
Elevated TG (%)46.9%45.2%54.1%0.01
HDL-C (mmol/L)1.21(1.01–1.48)1.21(1.02–1.46)1.2(0.99–1.53)0.90
Reduced HDL-C (%)40.1%39.5%42.5%0.35
Statin (%)60.3%58.2%67.1%< 0.01
FBG (mmol/L)6.38 ± 2.146.31 ± 2.016.72 ± 2.620.01
Elevated FBG (%)58.3%56.6%66.1%0.01
Diabetes (%)24.7%23.7%28.3%0.03
Antidiabetic therapy (%)24.2%22.8%29.2%< 0.01
Waist circumference (cm)84.18 ± 14.7583.71 ± 13.8985.86 ± 17.35< 0.01
Elevated waist circumference (%)47.5%45.7%54.0%< 0.01
eGFR (ml/min/1.73 m2)79.24 ± 29.1891.16 ± 18.8737.03 ± 17.91< 0.01
CKD22.0%
  1. BP: Blood pressure; CKD: Chronic kidney disease; eGFR: estimated glomerular filtration rate; FBG: Fasting blood glucose; HDL-C: High density lipoprotein-C; TG: Triglycerides;